UPDATE 2-Xeris Pharma's low blood sugar treatment wins FDA approval
September 10, 2019 at 14:43 PM EDT
The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon therapy that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday.